Avelios Medical secures 30 million euros

Avelios Medical wants to revolutionize everyday clinical practice with a modular platform and structured data. Sequoia Capital supports the startup with fresh capital.

Munich, February 6, 2025 - The Munich-based healthtech startup Avelios Medical is receiving 30 million euros in a Series A financing round. The investment is led by Sequoia Capital, with participation from existing investors Revent and HTGF. This makes the round one of the largest financing deals in the digital health sector in recent months.

Hospital information system as a solution for outdated IT

Avelios Medical is developing a modern hospital information system (HIS) designed to make digital patient care more efficient and secure. Many hospitals work with outdated IT systems that make day-to-day medical work more difficult. With a modular software platform and fully structured data, Avelios offers a flexible and AI-supported solution that can be adapted to the individual requirements of hospitals.

Growing demand for modern HIS solutions

The demand for innovative hospital information systems is increasing as SAP, a leading provider, withdraws from the market. Many hospitals are facing the challenge of renewing their IT infrastructure. Avelios is positioning itself as a future-proof alternative that reduces administrative overhead, prevents medication errors and improves patient care.

We were impressed by the technological depth and positive customer feedback. The company offers a modern solution that meets the needs of the healthcare sector.0

Anas Biad, Partner Sequoia Capital

Hospitals already rely on Avelios

Several well-known hospitals, including Sana Kliniken, LMU Munich and Hannover Medical School, already rely on Avelios software. The company intends to use the new funding to expand its team and support other hospitals in their digital transformation. We already reported on 2021 a successful financing round for Avelios Medical on the Startbase.